Showing 85 to 96 of 105 results


West Virginia Distributes $10.4 Million in Opioid Crisis Grants
West Virginia's West Virginia First Foundation announced $10.4 million in grants for 38 programs combating the opioid crisis, including child advocacy, recovery housing, and diversion programs, from a pool of 174 applications, with plans for additional funding.
West Virginia Distributes $10.4 Million in Opioid Crisis Grants
West Virginia's West Virginia First Foundation announced $10.4 million in grants for 38 programs combating the opioid crisis, including child advocacy, recovery housing, and diversion programs, from a pool of 174 applications, with plans for additional funding.
Progress
24% Bias Score


DOJ Sues CVS for Alleged Role in Opioid Crisis
The US Justice Department sued CVS, alleging the pharmacy chain unlawfully dispensed massive quantities of opioids and other controlled substances for over a decade, ignoring red flags and prioritizing speed over safety, contributing to the opioid crisis.
DOJ Sues CVS for Alleged Role in Opioid Crisis
The US Justice Department sued CVS, alleging the pharmacy chain unlawfully dispensed massive quantities of opioids and other controlled substances for over a decade, ignoring red flags and prioritizing speed over safety, contributing to the opioid crisis.
Progress
56% Bias Score


McKinsey to Pay $650 Million in Opioid Crisis Settlement
McKinsey & Company will pay $650 million to settle criminal charges for conspiring with Purdue Pharma to misbrand OxyContin, contributing to the US opioid crisis which resulted in nearly 100,000 overdose deaths annually, though recently decreased by 14%.
McKinsey to Pay $650 Million in Opioid Crisis Settlement
McKinsey & Company will pay $650 million to settle criminal charges for conspiring with Purdue Pharma to misbrand OxyContin, contributing to the US opioid crisis which resulted in nearly 100,000 overdose deaths annually, though recently decreased by 14%.
Progress
44% Bias Score


McKinsey to Pay $650 Million in Opioid Settlement
McKinsey & Company agreed to pay $650 million to settle federal charges for its role in boosting OxyContin sales, including $2 million to Virginia's Medicaid Fraud Control Unit; a former partner pleaded guilty to obstruction of justice.
McKinsey to Pay $650 Million in Opioid Settlement
McKinsey & Company agreed to pay $650 million to settle federal charges for its role in boosting OxyContin sales, including $2 million to Virginia's Medicaid Fraud Control Unit; a former partner pleaded guilty to obstruction of justice.
Progress
52% Bias Score


Ohio Supreme Court Overturns $650 Million Opioid Judgment
The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision could impact similar cases nationwide.
Ohio Supreme Court Overturns $650 Million Opioid Judgment
The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision could impact similar cases nationwide.
Progress
36% Bias Score


Ohio Supreme Court Overturns $650 Million Opioid Judgment Against Pharmacies
The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit brought by Lake and Trumbull counties, ruling that state law prohibits such public nuisance claims against pharmaceutical companies, potentially impacting similar cases nationwide.
Ohio Supreme Court Overturns $650 Million Opioid Judgment Against Pharmacies
The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit brought by Lake and Trumbull counties, ruling that state law prohibits such public nuisance claims against pharmaceutical companies, potentially impacting similar cases nationwide.
Progress
40% Bias Score

DOJ Sues CVS for Allegedly Filling Illegal Opioid Prescriptions
The US Department of Justice sued CVS on Wednesday for allegedly filling illegal opioid prescriptions from 2013 onward, violating the Controlled Substances Act, ignoring red flags, and contributing to patient deaths; this follows a $5 billion settlement with state and local governments in 2022 but r...

DOJ Sues CVS for Allegedly Filling Illegal Opioid Prescriptions
The US Department of Justice sued CVS on Wednesday for allegedly filling illegal opioid prescriptions from 2013 onward, violating the Controlled Substances Act, ignoring red flags, and contributing to patient deaths; this follows a $5 billion settlement with state and local governments in 2022 but r...
Progress
48% Bias Score

Justice Department Sues CVS Over Alleged Illegal Opioid Prescriptions
The US Department of Justice sued CVS on Wednesday for allegedly filling illegal opioid prescriptions from 2013 to the present, violating the Controlled Substances Act, contributing to the opioid crisis, and resulting in patient deaths; CVS denies the allegations but had previously paid a large sett...

Justice Department Sues CVS Over Alleged Illegal Opioid Prescriptions
The US Department of Justice sued CVS on Wednesday for allegedly filling illegal opioid prescriptions from 2013 to the present, violating the Controlled Substances Act, contributing to the opioid crisis, and resulting in patient deaths; CVS denies the allegations but had previously paid a large sett...
Progress
44% Bias Score

McKinsey Pays $650 Million to Settle Opioid Marketing Case
McKinsey & Company will pay $650 million to settle US claims that it helped market opioid painkillers, including advising Purdue Pharma on boosting OxyContin sales; a former McKinsey partner will plead guilty next month, and the firm is prohibited from opioid marketing for five years.

McKinsey Pays $650 Million to Settle Opioid Marketing Case
McKinsey & Company will pay $650 million to settle US claims that it helped market opioid painkillers, including advising Purdue Pharma on boosting OxyContin sales; a former McKinsey partner will plead guilty next month, and the firm is prohibited from opioid marketing for five years.
Progress
36% Bias Score

Crack Cocaine Crisis in Germany: 610 Deaths in 2023
Crack cocaine use is dramatically increasing in Germany, causing 610 deaths in 2023, nearing heroin's death toll (712), due to increased cocaine production and distribution, and the lack of effective treatment.

Crack Cocaine Crisis in Germany: 610 Deaths in 2023
Crack cocaine use is dramatically increasing in Germany, causing 610 deaths in 2023, nearing heroin's death toll (712), due to increased cocaine production and distribution, and the lack of effective treatment.
Progress
48% Bias Score

Ohio Supreme Court Overturns $650 Million Opioid Judgment
The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies. This decision, based on the interpretation of Ohio Product Liability Act, c...

Ohio Supreme Court Overturns $650 Million Opioid Judgment
The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies. This decision, based on the interpretation of Ohio Product Liability Act, c...
Progress
40% Bias Score

Ohio Supreme Court Overturns $650 Million Opioid Judgment
The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision may affect similar cases nationwide.

Ohio Supreme Court Overturns $650 Million Opioid Judgment
The Ohio Supreme Court overturned a $650 million judgment against CVS, Walgreens, and Walmart in an opioid lawsuit, ruling that state law prohibits counties from using public nuisance claims against pharmaceutical companies; this decision may affect similar cases nationwide.
Progress
48% Bias Score
Showing 85 to 96 of 105 results